TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 89 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $3,219,000 | -42.5% | 1,048,642 | +17.9% | 0.50% | -45.2% |
| Q4 2017 | $5,601,000 | -9.0% | 889,100 | -1.2% | 0.92% | +0.5% |
| Q3 2017 | $6,156,000 | +415.6% | 900,000 | +462.3% | 0.91% | +1280.3% |
| Q3 2015 | $1,194,000 | -93.8% | 160,047 | -83.3% | 0.07% | -96.7% |
| Q3 2014 | $19,137,000 | -66.5% | 959,247 | -77.3% | 2.01% | -28.6% |
| Q2 2014 | $57,082,000 | +161.0% | 4,231,494 | +110.7% | 2.81% | +32.6% |
| Q1 2014 | $21,868,000 | -26.3% | 2,008,125 | -8.4% | 2.12% | -45.8% |
| Q4 2013 | $29,654,000 | +45.3% | 2,193,328 | +22.3% | 3.91% | +7.9% |
| Q3 2013 | $20,408,000 | +103.2% | 1,793,328 | +25.6% | 3.62% | +84.5% |
| Q2 2013 | $10,041,000 | – | 1,428,314 | – | 1.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 293,675 | $14,061,000 | 4.76% |
| BB BIOTECH AG | 1,507,114 | $71,497,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 893,076 | $42,368,000 | 1.77% |
| Opaleye Management Inc. | 65,000 | $3,084,000 | 1.23% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 390,294 | $18,515,000 | 1.14% |
| Granite Point Capital Management, L.P. | 75,206 | $3,568,000 | 1.04% |
| Granahan Investment Management | 705,601 | $33,474,000 | 0.95% |
| Iguana Healthcare Management, LLC | 50,000 | $2,372,000 | 0.75% |
| Eventide Asset Management | 290,000 | $13,758,000 | 0.74% |
| Rhenman & Partners Asset Management AB | 107,400 | $5,095,000 | 0.61% |